Notably, SEMA4D is overexpressed in various malignancies compared with normal tissue cells, such as prostate cancer [33], pancreatic cancer [18], cervical cancer [23], and particularly CRC [17, 24]. This evidence concerns the gene SEMA4D and familial pancreatic carcinoma.